Xiangyu Medical Co.,Ltd

SHSE:688626 Stock Report

Market Cap: CN¥4.9b

Xiangyu MedicalLtd Past Earnings Performance

Past criteria checks 1/6

Xiangyu MedicalLtd has been growing earnings at an average annual rate of 0.4%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 11.6% per year. Xiangyu MedicalLtd's return on equity is 6%, and it has net margins of 17.1%.

Key information

0.4%

Earnings growth rate

-6.0%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate11.6%
Return on equity6.0%
Net Margin17.1%
Last Earnings Update30 Sep 2024

Recent past performance updates

Why Xiangyu MedicalLtd's (SHSE:688626) Soft Earnings Are Just The Beginning Of Its Problems

Nov 06
Why Xiangyu MedicalLtd's (SHSE:688626) Soft Earnings Are Just The Beginning Of Its Problems

Xiangyu MedicalLtd's (SHSE:688626) Performance Raises Some Questions

Apr 24
Xiangyu MedicalLtd's (SHSE:688626) Performance Raises Some Questions

Recent updates

Xiangyu MedicalLtd (SHSE:688626) Has A Somewhat Strained Balance Sheet

Dec 11
Xiangyu MedicalLtd (SHSE:688626) Has A Somewhat Strained Balance Sheet

Why Xiangyu MedicalLtd's (SHSE:688626) Soft Earnings Are Just The Beginning Of Its Problems

Nov 06
Why Xiangyu MedicalLtd's (SHSE:688626) Soft Earnings Are Just The Beginning Of Its Problems

Further Upside For Xiangyu Medical Co.,Ltd (SHSE:688626) Shares Could Introduce Price Risks After 41% Bounce

Oct 09
Further Upside For Xiangyu Medical Co.,Ltd (SHSE:688626) Shares Could Introduce Price Risks After 41% Bounce

Xiangyu Medical Co.,Ltd (SHSE:688626) Looks Inexpensive But Perhaps Not Attractive Enough

Aug 24
Xiangyu Medical Co.,Ltd (SHSE:688626) Looks Inexpensive But Perhaps Not Attractive Enough

Xiangyu MedicalLtd (SHSE:688626) Seems To Use Debt Quite Sensibly

Jul 04
Xiangyu MedicalLtd (SHSE:688626) Seems To Use Debt Quite Sensibly

Xiangyu MedicalLtd's (SHSE:688626) Performance Raises Some Questions

Apr 24
Xiangyu MedicalLtd's (SHSE:688626) Performance Raises Some Questions

CN¥50.78: That's What Analysts Think Xiangyu Medical Co.,Ltd (SHSE:688626) Is Worth After Its Latest Results

Apr 21
CN¥50.78: That's What Analysts Think Xiangyu Medical Co.,Ltd (SHSE:688626) Is Worth After Its Latest Results

Capital Allocation Trends At Xiangyu MedicalLtd (SHSE:688626) Aren't Ideal

Apr 18
Capital Allocation Trends At Xiangyu MedicalLtd (SHSE:688626) Aren't Ideal

Pinning Down Xiangyu Medical Co.,Ltd's (SHSE:688626) P/E Is Difficult Right Now

Mar 26
Pinning Down Xiangyu Medical Co.,Ltd's (SHSE:688626) P/E Is Difficult Right Now

Revenue & Expenses Breakdown

How Xiangyu MedicalLtd makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

SHSE:688626 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24710121244138
30 Jun 24748176237125
31 Mar 24771228221115
31 Dec 23745227213107
30 Sep 2367421219499
30 Jun 2360219318396
31 Mar 2354715418396
31 Dec 2248912517692
30 Sep 2252916317489
30 Jun 2252815616483
31 Mar 2250817715474
31 Dec 2152320214369
30 Sep 2153321214262
30 Jun 2152620513561
31 Mar 2153121012559
31 Dec 2049619611652
31 Dec 1942712912541
31 Dec 183598012629
31 Dec 17289648017

Quality Earnings: 688626 has a high level of non-cash earnings.

Growing Profit Margin: 688626's current net profit margins (17.1%) are lower than last year (31.4%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 688626's earnings have grown by 0.4% per year over the past 5 years.

Accelerating Growth: 688626's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 688626 had negative earnings growth (-42.7%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.8%).

Return on Equity

High ROE: 688626's Return on Equity (6%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 06:00
End of Day Share Price 2024/12/25 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Xiangyu Medical Co.,Ltd is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhu ChenCitic Securities Co., Ltd.
Shuo SongCitic Securities Co., Ltd.
Xiao Wei LinEverbright Securities Co. Ltd.